Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer;Proporção de linfonodos metastáticos como variável independente de prognóstico no câncer colorretal

Revista Brasileira de Coloproctologia

Volumn 28, Issue 4, 2008, Pages 431-442

  Priolli, Denise Gonçalves ^a,d   Cardinalli, Izilda Aparecida ^a   Alfredo, Camila Helaehil ^a   Spadari, Ana Paula Pimentel ^a   Máximo, Felipe Ródrigues ^a   Margarido, Nelson Fontana ^b   Martinez, Carlos Augusto Real ^a,c  

^a UNIVERSIDADE SÃO FRANCISCO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital Universitario Sao Francisco   (Brazil)

^d NONE   (Brazil)

Author keywords

Colorectal neoplasms; Lymph node excision; Lymph nodes; Prognosis; Survival analysis; Survival rate

Indexed keywords

EID: 63749116579     PISSN: 01019880     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0101-98802008000400005     Document Type: Article

References (50)

1. Surveillance epidemiology and end results (SEER). National Cancer Institute. [cited 2008 mar 21]. Avaliable from: http://seer.cancer.gov/ statfacts/html/colorect/html
2. Sanfelippo PM, Beahrs OH. Factors in the prognosis of adenocarcinoma of the colon and rectum. Arch Surg.1972;104:401-6.
3. Cain AS, Longino LA. Carcinoma of the colon in children. J Pediatr Surg.1970; 5:527-32.
4. Wolmark N, Wieand HS, Rockette HE, Fischer B, Glass A, Lawrence W, et al. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials.1983;198:743-52.
5. Grinnel RS. The grading and prognosis of carcinoma of the colon and rectum. Ann Surg.1939;109:500-33.
6. Dukes CE. The classification of cancer of the rectum. J Pathol.1932;35:323-32.
7. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg.1954;139:846-51.
8. Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer.1958;12:309-20.
9. Halvorsen TB, Sein E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. J Clin Pathol.1988;41:1068-72.
10. Martinez CAR, Priolli DG, Cardinalli IA, Piovesam H, Pereira JA, Waisberg J, et al. Correlação entre o padrão de distribuição tecidual e os valores séricos do antígeno carcinoembrionário em doentes com câncer. Rev bras Coloproct.2006; 26:41-53.
11. Cutait R. Contribuição ao estudo do antigeno carcinoembrionário e dos antígenos de superfície ABH no cancer colo-retal. Tese (Livre Docência) - Faculdade de Medicina da Universidade de São Paulo, São Paulo, 1991. 96p.
12. Khankhanian N, Mavligit GM, Russell WO, Schimek M. Prognostic significance of vascular invasion in colorectal cancer of Dukes' B class. Cancer.1977;39:1195-200.
13. Cruz JV, Cutait R, Martinez CAR, Bevilacqua RG, Leite KRM, Margarido NF. Importancia prognostica da invasão neural no câncer colorretal. Estudo imunoistoquímico com a proteína S-100. Rev bras Coloproct.2006;26:280-93.
14. Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J, et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol.2004;221:564-71.
15. Sigurdson ER: Lymph node dissection: Is it diagnostic or therapeutic? J Clin Oncol 2003;21:965-7.
16. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol.2003; 21:1029-34.
17. Wong JH, Severino R, Honnebier MB. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol.1999;17:2896-900.
18. LeVoyer TE, Sigurdson ER, Hanlon AR, Mayer RJ, MacDonald JS, Catalano PJ. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol.2003; 21:2912-9.
19. Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol.2007;96:95-101.
20. Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D'Ugo D. Ratio of metastatic lymph nodes: Impact on staging and survival of gastric cancer. Eur J Surg Oncol.2007;34:519-24.
21. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167:1295-8.
22. Weir L, Speers C, D'yachkova Y, Olivotto IA. Prognostic significance of the number of axillary lymph nodes removed in patients with node negative breast cancer. J Clin Oncol.2002;20:1793-9.
23. Berger AC, Watson JC, Ross EA, Hoffman JP. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg.2004;70:235-40.
24. Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, et al. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol.2007; 14:1712-7.
25. Berger AC, Sigurdson ER, Le Voyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol.2005;23:8706-12.
26. Wang J, Hasset JM, Dayton MT, Kulaylat MN. Lymphy node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2008;15:1600-8.
27. Derwinger K, Carlsson G, Gustavsson B. A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol. 2007;34:771-5.
28. Trufelli DC, da Costa Miranda V, Palos CC, Ramos E, Abrão MN, da Silva VA, et al. Positive/total dissected lymph nodes ratio as a prognostic factor in colorectal cancer. Rev Ass Med Bras.2007;53:539-42.
29. Schumacher P, Dineen S, Barnett C Jr, Fleming J, Anthony T. The metastatic lymph node ratio predicts survival in colorectal cancer. Am J Surg.2007;194:827-31.
30. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, et al. National Cancer Institute Expert Panel. Guideline 2000 for Colon and Rectal Cancer Surgery. J Nat Cancer Inst.2001;93:583-96.
31. SPSS® Inc.; Ilinois, USA
32. Collaborative staging and coding manual. American Joint Committee on Cancer. [cited 2008 mar 21]. Avaliable in URL from: http://www.cancerstaging.org
33. Pinho MSL. Estadiamento molecular do cancer colorretal: o futuro se aproxima. Rev bras Coloproct.2005;25:279-84.
34. Hermanek P, Giedl J, Dworak O. Two programs for examination of regional lymph nodes in colorectal carcinoma with regard to the new pN classification. Path Res Pract.1989;185:867-73.
35. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol.1996;106:209-16.
36. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg.2006;244:602-10.
37. Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A. Metastases in small nodes from colon cancer. Arch Surg.1987;122:1253-6.
38. Mönig SP, Baldus SE, Zirbes TK, Schröder W, Lindemann DG, Dienes HP, et al. Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol.1999;6:579-81.
39. Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, et al. Validation of lymphatic mapping in colorectal cancer: In vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol.2001;8:150-7.
40. Wong SL, Ji H, Hollenbeck BR, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA.2007;298:2149-54.
41. Schrag D, Panageas KS, Riedel E, Hsieh L, Bach PB, Guillem JB, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol.2003;83:68-78.
42. Meyerhardt JA, Castelano PJ, Schrag D, Ayanian JZ, Haller DG, Mayer RJ, et al. Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Inter Med. 2003;139:649-57.
43. Haboubi NY, Clark P, Kaftan SM, Schofield PF. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med.1992;85:386-8
44. Palma RT, Waisberg J, Bromberg S, Simão AB, Godoy AC. Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis.2003;5:164-8.
45. Messerini L, Cianchi F, Cortesini C, Comin CE. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum Pathol. 2006;37:1259-67.
46. Feistein AR, Sosin DM, Wells CK: The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med.1985;312:1604-8.
47. Inoue K, Nakane Y, Iiyama H, Sato M, Kambara T, Nakai K, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol.2002;9:27-34.
48. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Nishimura G, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol.2002;9:775-84
49. Mammen JM, James LE, Molloy M, Williams A, Wray CJ, Sussman JJ. The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry. Am J Surg.2007:194;349-54.
50. Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J. Surg Oncol.2006;93:439-45.